FDA Inspection 1119575 — Malladi Drugs and Pharmaceuticals Ltd.
The FDA completed an inspection of Malladi Drugs and Pharmaceuticals Ltd. on January 31, 2020 in Gajulamandyam. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 31, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Gajulamandyam (India)